» Articles » PMID: 34642411

Dynamic Alterations in Monocyte Numbers, Subset Frequencies and Activation Markers in Acute and Convalescent COVID-19 Individuals

Abstract

Monocytes are thought to play an important role in host defence and pathogenesis of COVID-19. However, a comprehensive examination of monocyte numbers and function has not been performed longitudinally in acute and convalescent COVID-19. We examined the absolute counts of monocytes, the frequency of monocyte subsets, the plasma levels of monocyte activation markers using flowcytometry and ELISA in seven groups of COVID-19 individuals, classified based on days since RT-PCR confirmation of SARS-CoV2 infection. Our data shows that the absolute counts of total monocytes and the frequencies of intermediate and non-classical monocytes increases from Days 15-30 to Days 61-90 and plateau thereafter. In contrast, the frequency of classical monocytes decreases from Days 15-30 till Days 121-150. The plasma levels of sCD14, CRP, sCD163 and sTissue Factor (sTF)-all decrease from Days 15-30 till Days 151-180. COVID-19 patients with severe disease exhibit higher levels of monocyte counts and higher frequencies of classical monocytes and lower frequencies of intermediate and non-classical monocytes and elevated plasma levels of sCD14, CRP, sCD163 and sTF in comparison with mild disease. Thus, our study provides evidence of dynamic alterations in monocyte counts, subset frequencies and activation status in acute and convalescent COVID-19 individuals.

Citing Articles

A cross-sectional study of laboratory parameters 5-6 months after the first COVID-19 infection.

Zore T, Lojk J, Rebersek K, Alic E, Primozic U, Stiglic A Heliyon. 2025; 11(4):e42535.

PMID: 40034304 PMC: 11872526. DOI: 10.1016/j.heliyon.2025.e42535.


Identification of an immunological signature of long COVID syndrome.

Guerrera G, Sambucci M, Timperi E, Picozza M, Misiti A, Placido R Front Immunol. 2025; 15():1502937.

PMID: 39845978 PMC: 11750999. DOI: 10.3389/fimmu.2024.1502937.


Utility of Hematological and Biochemical Parameters as a Screening Tool for Assessing Coronavirus Disease 2019 Infection and its Severity.

Alam S, Khan S, Jain V, Kashyap V, Kapur P J Microsc Ultrastruct. 2025; 12(4):214-220.

PMID: 39811594 PMC: 11729020. DOI: 10.4103/jmau.jmau_59_22.


Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological Changes.

Kumar S, Ramaraju K, Kakarla M, Eranezhath S, Chenthamarakshan C, Alagesan M Cureus. 2024; 16(9):e68392.

PMID: 39355453 PMC: 11444340. DOI: 10.7759/cureus.68392.


Elucidating the Immune Response to SARS-CoV-2: Natural Infection versus Covaxin/Covishield Vaccination in a South Indian Population.

Vanamudhu A, Devi Arumugam R, Nancy A, Selvaraj N, Moiden K, Hissar S Viruses. 2024; 16(8).

PMID: 39205152 PMC: 11360806. DOI: 10.3390/v16081178.


References
1.
Peruzzi B, Bencini S, Capone M, Mazzoni A, Maggi L, Salvati L . Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection. Immunology. 2020; 161(4):345-353. PMC: 7692244. DOI: 10.1111/imm.13254. View

2.
Sandler N, Wand H, Roque A, Law M, Nason M, Nixon D . Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011; 203(6):780-90. PMC: 3071127. DOI: 10.1093/infdis/jiq118. View

3.
Vasse M, Zuber B, Goubeau L, Ballester M, Roumier M, Delcominette F . A low level of CD16 monocytes in SARS-CoV-2 infected patients is a marker of severity. Clin Chem Lab Med. 2021; 59(7):1315-1322. DOI: 10.1515/cclm-2020-1801. View

4.
Baker J, Hullsiek K, Bradford R, Prosser R, Tracy R, Key N . Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients. J Acquir Immune Defic Syndr. 2013; 63(3):367-71. PMC: 3683107. DOI: 10.1097/QAI.0b013e3182910121. View

5.
Bao J, Li C, Zhang K, Kang H, Chen W, Gu B . Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta. 2020; 509:180-194. PMC: 7274996. DOI: 10.1016/j.cca.2020.06.009. View